Molecular homing and retention of muscle membrane stabilizing copolymers by non-invasive optical imaging in vivo

[1]  Beob Soo Kim,et al.  Size-tunable PEG-grafted copolymers as a polymeric nanoruler for passive targeting muscle tissues. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Asher Mullard.  Sarepta’s DMD gene therapy falls flat , 2021, Nature reviews. Drug discovery.

[3]  Haiyan Chen,et al.  Near-infrared small molecular fluorescent dyes for photothermal therapy , 2019, Chinese Chemical Letters.

[4]  F. Bates,et al.  Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury , 2019, JACC. Basic to translational science.

[5]  Lauren M. Aufdembrink,et al.  Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts. , 2019, Journal of molecular and cellular cardiology.

[6]  Y. Sham,et al.  Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers , 2018, Skeletal Muscle.

[7]  Y. Sham,et al.  All-Atom Molecular Dynamics-Based Analysis of Membrane-Stabilizing Copolymer Interactions with Lipid Bilayers Probed under Constant Surface Tensions. , 2017, The journal of physical chemistry. B.

[8]  O. Velev,et al.  Investigation of interfacial properties of pure and mixed poloxamers for surfactant-mediated shear protection of mammalian cells. , 2017, Colloids and surfaces. B, Biointerfaces.

[9]  Mihee M. Kim,et al.  PEO-PPO Diblock Copolymers Protect Myoblasts from Hypo-Osmotic Stress In Vitro Dependent on Copolymer Size, Composition, and Architecture. , 2017, Biomacromolecules.

[10]  Mihee M. Kim,et al.  Chemical End Group Modified Diblock Copolymers Elucidate Anchor and Chain Mechanism of Membrane Stabilization. , 2017, Molecular pharmaceutics.

[11]  Shan Sun,et al.  Preventive Effects of Poloxamer 188 on Muscle Cell Damage Mechanics Under Oxidative Stress , 2016, Annals of Biomedical Engineering.

[12]  M. Muhammed,et al.  Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging , 2016, Journal of Nanobiotechnology.

[13]  J. Metzger,et al.  Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments. , 2016, American Journal of Physiology. Heart and Circulatory Physiology.

[14]  F. Bates,et al.  Intracoronary Poloxamer 188 Prevents Reperfusion Injury in a Porcine Model of ST-Segment Elevation Myocardial Infarction , 2016, JACC. Basic to translational science.

[15]  R. Perlingeiro,et al.  Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo , 2015, Molecular therapy. Methods & clinical development.

[16]  J. Wilkinson,et al.  Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice , 2015, PloS one.

[17]  R. Neumar,et al.  Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest. , 2015, Resuscitation.

[18]  K. Flanigan.  Duchenne and Becker muscular dystrophies. , 2014, Neurologic clinics.

[19]  Laura D. Hughes,et al.  Choose Your Label Wisely: Water-Soluble Fluorophores Often Interact with Lipid Bilayers , 2014, PloS one.

[20]  J. Metzger,et al.  Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization. , 2014, Journal of molecular and cellular cardiology.

[21]  P. Gervais,et al.  Exploration of Lipid Metabolism in Relation with Plasma Membrane Properties of Duchenne Muscular Dystrophy Cells: Influence of L-Carnitine , 2012, PloS one.

[22]  Songi Han,et al.  Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization. , 2012, Biomacromolecules.

[23]  J. Marks,et al.  Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (I) effect of polymer hydrophobicity on its ability to protect liposomes from peroxidation. , 2012, Biomacromolecules.

[24]  Y. Itoyama,et al.  Continuous administration of poloxamer 188 reduces overload-induced muscular atrophy in dysferlin-deficient SJL mice , 2012, Neuroscience Research.

[25]  P. Turner,et al.  Administration of substances to laboratory animals: routes of administration and factors to consider. , 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.

[26]  E. Hoffman,et al.  Membrane Sealant Poloxamer P188 Protects Against Isoproterenol Induced Cardiomyopathy in Dystrophin Deficient Mice , 2011, BMC cardiovascular disorders.

[27]  I. Graham,et al.  Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  J. Kornegay,et al.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.

[29]  Soojin Lim,et al.  NIR dyes for bioimaging applications. , 2010, Current opinion in chemical biology.

[30]  Akinori Nakamura,et al.  Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs , 2009, Annals of neurology.

[31]  M. Carignano,et al.  Effects of block copolymer's architecture on its association with lipid membranes: experiments and simulations. , 2007, The Journal of chemical physics.

[32]  Raphael C. Lee,et al.  Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188. , 2007, Biochimica et biophysica acta.

[33]  A. Rabinowitz,et al.  Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology , 2006, Nature Medicine.

[34]  S. Day,et al.  Dystrophic heart failure blocked by membrane sealant poloxamer , 2005, Nature.

[35]  C. Porter,et al.  Subcutaneous drug delivery and the role of the lymphatics. , 2005, Drug discovery today. Technologies.

[36]  A. Rabinowitz,et al.  Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Raphael C. Lee,et al.  Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. , 2004, Burns : journal of the International Society for Burn Injuries.

[38]  D. Duan,et al.  Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. , 2004, Human molecular genetics.

[39]  Raphael C. Lee,et al.  Subcutaneous tri‐block copolymer produces recovery from spinal cord injury , 2004, Journal of neuroscience research.

[40]  M. Firestone,et al.  Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymers with lipid bilayers. , 2003, Biomacromolecules.

[41]  Alexander V Kabanov,et al.  Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. , 2003, Advanced drug delivery reviews.

[42]  Ka Yee C. Lee,et al.  Comparative Study of Poloxamer Insertion into Lipid Monolayers , 2003 .

[43]  R. Emanuele,et al.  Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. , 2002, Journal of pharmaceutical sciences.

[44]  Alexander V Kabanov,et al.  Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[45]  P. Culbreth,et al.  Pharmacokinetics of a novel surface‐active agent, purified poloxamer 188, in rat, rabbit, dog and man , 2002, Biopharmaceutics & drug disposition.

[46]  Raphael C. Lee,et al.  Direct observation of poloxamer 188 insertion into lipid monolayers. , 2002, Biophysical journal.

[47]  S. Shaikh,et al.  Lipid phase separation in phospholipid bilayers and monolayers modeling the plasma membrane. , 2001, Biochimica et biophysica acta.

[48]  Raphael C. Lee,et al.  Surfactant Sealing of Membranes Permeabilized by Ionizing Radiation , 2000, Radiation research.

[49]  B. Mokri,et al.  Duchenne dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber , 1998, Neurology.

[50]  M. Steinberg,et al.  RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study. , 1997, Blood.

[51]  R. Gibbons,et al.  Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. , 1996, Circulation.

[52]  M. Toner,et al.  Effectiveness of Poloxamer 188 in Arresting Calcein Leakage from Thermally Damaged Isolated Skeletal Muscle Cells a , 1994, Annals of the New York Academy of Sciences.

[53]  R. Lee,et al.  Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. M. Bates,et al.  50th Anniversary Perspective: Block Polymers—Pure Potential , 2017 .

[55]  Xi-ping Chen,et al.  Poloxamer-188 Can Attenuate Blood–Brain Barrier Damage to Exert Neuroprotective Effect in Mice Intracerebral Hemorrhage Model , 2014, Journal of Molecular Neuroscience.

[56]  A. Ossipov,et al.  Duchenne muscular dystrophy , 2004 .